Roblitinib |
Roblitinib : Reversible-Covalent Inhibitor of FGFR4
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| FGFR4 |
|
|
Reversible
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
KINOMEscan
Selectivity Assessment Description:
1000-fold selectivity for FGFR4 compared to the next most potent kinase inhibited (Aurora A: IC50 ...
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Enzyme and Receptor screens
Selectivity Assessment Description:
In enzyme and receptor screens, 84 exhibited no appreciable activity at a concentration of 10 μM aga ...
Potency Cellular
In Vitro
FGFR4
Mode of Action: Reversible
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.0c01019
In Vivo Validations
Mouse, Rat, Dog
Dose: 1 IV, 3 PO mg/Kg (M), 0.5 IV, 3 PO mg/Kg (R), 0.1 IV, 0.3 PO mg/Kg (D)
Route of delivery:
Intravenous, Oral
Plasma half life:
1.4 (M), 4.4(R), 6.5 (D) h
Systemic clearance:
28 (M), 19(R), 8 (D) mL/min/Kg
DOI Reference: 10.1021/acs.jmedchem.0c01019
Chemical Information
| Molecular Formula | C25H30N8O4 |
| SMILEs | COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N |
| InChI | InChI=1S/C25H30N8O4/c1-31-7-8-32(23(35)15-31)14-18-10-17-4-3-6-33(24(17)29-21(18)16-34)25(36)30-22-11-20(27-5-9-37-2)19(12-26)13-28-22/h10-11,13,16H,3-9,14-15H2,1-2H3,(H2,27,28,30,36) |
| Molecular weight | 506.24 Da |
| AlogP | 0.0 |
| HBond acceptors | 12 |
| HBond donors | 2 |
| Atoms | 67 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.